Introduction
============

Epithelial--mesenchymal transition (EMT) is essential during embryo development and found in common pathologies such as organ fibrosis and in the initiation of metastasis for cancer progression. EMT is a process that converts an epithelium into individual mesenchymal cells. Cells lose their apico-basal polarity and cell--cell adhesion, and gain migratory and invasive properties to become mesenchymal cells ([@bib61]; [@bib22]; [@bib32]). However, not all EMTs go to completion, and cells can have various degrees of mesenchymal phenotypes. In particular, cell--cell adhesion can be partially conserved. Interestingly, the ability to retain stable cell--cell contacts does not correlate with the capability of undergoing collective cell migration (CCM), a process during which a group of cells cooperate to migrate in a coordinated manner. Indeed, collective behavior can be found in cells that have been described as epithelial, mesenchymal, or as having an intermediate phenotype ([@bib47]; [@bib18]; [@bib58]). It is unclear what such intermediate phenotypes represent and what advantage, if any, they would confer on cells compared with fully epithelial or mesenchymal phenotypes. In particular, this raises the question of the role of cell--cell adhesion remodeling during EMT, especially when the cell population that activates an EMT program has to subsequently undergo CCM.

Here we use the neural crest (NC) cell population to (1) explore how cell--cell adhesion is regulated in a collectively migrating cell population and to (2) assess the implication of maintaining or disrupting cell--cell adhesion during collective migration.

NC cells are a highly migratory and multipotent embryonic cell population, whose invasive behavior has been likened to malignant invasion ([@bib36]; [@bib46]). It has been well characterized that the initiation of NC migration during embryo development requires activation of an EMT program, which involves a qualitative and quantitative change of cell adhesion ([@bib50]; [@bib16]; [@bib57]). Migratory *Xenopus laevis* NC cells have been described as a pseudoepithelial cell population that progressively disassemble their cell--cell junctions ([@bib1]). In this system, cells become fully migratory before complete cell--cell dissociation, which allows us to address specifically the role of cell--cell dissociation during CCM in vivo.

Looking for candidate regulators of cell--cell adhesion, we found incipient data linking lysophosphatidic acid (LPA) signaling with changes in cadherin function during EMT in both cancer and NC cells ([@bib51]; [@bib21]; [@bib27]; [@bib24]; [@bib34]). The cellular activities controlled by LPA signaling are diverse, including proliferation, cell motility, chemotaxis, tumor invasion, gap-junction closure, tight junction opening, etc. ([@bib37]). This diversity of biological functions, as well as some apparent different cellular responses triggered by LPA, is likely related to the fact that LPA can bind any of six distinct receptors ([@bib33]). In addition, some level of redundancy has been described in mammalian embryos ([@bib10],[@bib11], [@bib12]), making impossible to characterize the biological activity of each LPA receptor using knockout mice.

Here we studied the specific role of LPA via LPAR2 during *Xenopus* NC cell development. Our results show that LPAR2 is essential for NC migration in vivo by controlling the internalization of N-cadherin. Importantly, LPAR2-induced cell--cell dissociation is critical only when cells are challenged into migrating through interstices in vivo or in vitro. Conversely, forcing cells to fully abolish cell--cell adhesion blocks migration in vivo but enhances dispersion in vitro. Thus down-regulation of cell--cell contacts has to be mild to endow the NC population with enough plasticity to invade its surroundings without abolishing cell cooperation required for collectiveness. LPA has been widely studied as a regulator of guanine nucleotide exchange factors (GEFs) for RhoA ([@bib40]; [@bib66]) but LPA function as a negative regulator of cell--cell adhesion by controlling N-cadherin endocytosis has never been shown before. Similarly, the role of cadherin endocytosis during EMT has been well characterized ([@bib43]), but its ability to control tissue plasticity necessary for in vivo CCM has not been previously revealed.

Our work offers novel insight on how cells can balance the need to migrate as individual cells, in an environment where physical constraints are present, with the need to maintain a certain degree of cooperation via cell--cell adhesion. We anticipate that similar fine-tuning of cell--cell contact during collective migration in vivo occurs in other systems such as carcinoma cells or gastrulating mesoderm.

Results
=======

We first looked at the expression of several components of the LPA signaling pathway and found that LPA receptor 2 (LPAR2) is expressed in the whole NC region at premigratory stages as compared with the NC marker *FoxD3* ([Fig. 1 A](#fig1){ref-type="fig"}), and seems to be progressively lost at late migratory stages, as it is detected only in subpopulations of NC cells after these cells have reach the ventral part of the head ([Fig. 1 B](#fig1){ref-type="fig"} and [Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp1}). LPAR1 is found in the otic vesicle and in the ectoderm, but not in the NC (Fig. S1 B). Autotaxin (ATX), one of the extracellular enzymes required for LPA synthesis ([@bib62]; [@bib23]), is weakly expressed at premigratory stages and found in a subpopulation of migratory NC cells (Fig. S1 C). We designed an antisense Morpholino against LPAR2 and tested its ability to silence a reporter containing its target sequence ([Fig. 1, C and D](#fig1){ref-type="fig"}). Blocking LPAR2 ([Fig. 1, E and F](#fig1){ref-type="fig"}) or that of ATX (Fig. S1 D) impaired NC migration in vivo without affecting NC induction (Fig. S1, E and F). We then checked that LPAR2 was required only in NC cells and not in their surrounding tissues by grafting morphant cells into control host embryos, or the converse experiment of grafting control cells into an LPAR2MO-injected host ([Fig. 1 G](#fig1){ref-type="fig"}). Cells injected with Fluorescein-dextran (FDx) as a control were able to migrate after being grafted onto a host ([Fig. 1 H](#fig1){ref-type="fig"}, left). LPAR2MO cells did not migrate into the host embryo ([Fig. 1 H](#fig1){ref-type="fig"}, middle), whereas LPAR1MO cells migrated as well as control cells ([Fig. 1 H](#fig1){ref-type="fig"}, right). Finally, control NC cells grafted into LPAR2MO embryos migrated normally ([Fig. 1 I](#fig1){ref-type="fig"}). These results show that LPA signaling within the NC via LPAR2 (but not LPAR1) is required for NC migration.

![**LPAR2 signaling is required for in vivo NC migration.** (A) In situ hybridization for *Foxd3* and *LPAR2*. (B) In situ hybridization for *Twist* and *LPAR2*. Asterisks indicate eyes. (C) Control Morpholino coinjected with membrane-mCherry into animal caps expressing 5′UTR-LPAR2GFP. (D) LPAR2 Morpholino coinjected with membrane-mCherry into animal caps expressing 5′UTR-LPAR2GFP. Note the absence of LPAR2-GFP fluorescence in the cell injected with LPAR2MO. (E) Frontal view of embryos injected with Control MO (CMO) or LPAR2MO, *Foxd3* in situ hybridization. Asterisks, eyes; Inj., injected side; red lines, normal migration in control side. (F) LPAR2MO-injected embryos have NC migration defects (41 embryos were analyzed). Student's *t* test (two-tailed): \*\*\*, P \< 0.005; errors bars indicate SD. (G) Grafting procedure. (H) Graft of control (left) or LPAR2MO (middle) or LPAR1MO cells (right) labeled with FDx (green) into host embryos. (I) Graft of control NC cells labeled with rhodamine-dextran (RDx, red) into LPAR2MO host (FDx, green). Bars: (A, B, E, H, and I) 0.5 mm; (C and D) 100 µm.](JCB_201402093_Fig1){#fig1}

LPAR2 phosphorylation increases at the onset of NC migration ([Fig. 2, A and B](#fig2){ref-type="fig"}). Although this increase in LPAR2 phosphorylation is quite reproducible, we were not able to show a statistically significant difference. Therefore we decided to test for a role of this phosphorylation on NC migration by mutating the phosphorylation sites. Two main putative phosphorylation sites are present in the cytoplasmic tail of LPA receptors: Tyrosine-317 (Y^317^) and Serine-324 (S^324^). However, S^324^ is the only site conserved across both LPAR1 and LPAR2 (Fig. S1, G and H), making it likely to be the most relevant site for signaling. Importantly, a single mutation targeting S^324^ in the cytoplasmic tail of LPAR2 (LPAR2SA) was sufficient to abolish phosphorylation of LPAR2 ([Fig. 2 C](#fig2){ref-type="fig"}). The inhibition of NC migration by LPAR2MO was rescued by overexpression of an mRNA encoding full-length LPAR2, which does not hybridize with LPAR2MO, but not by the nonphosphorylatable form LPAR2SA ([Fig. 2, D and E](#fig2){ref-type="fig"}). Together these results indicate that LPA signaling and phosphorylation of LPAR2 are essential for in vivo NC migration.

![**LPAR2 phosphorylation is required for in vivo NC migration.** (A) Western blot of whole LPAR2 with Phos-tag PAGE showing that the phosphorylated forms of LPAR2 (Ph-LPAR2) become predominant at the onset of NC migration (stage 19). nonPh-LPAR2, nonphosphorylated LPAR2; α-Tub, α-Tubulin. (B) Normalized ratio of PhoshoLPAR2 and Phospho+nonphosphoLPAR2. The experiment was done four times. A representative gel and a representative graph showing the ratio of Phospho-LPAR2/Total LPAR2 are depicted in A and B, respectively. (C) Western blot of control (LPAR2) or point mutation S^324^A LPAR2 (LPAR2SA) cytoplasmic tail with Phos-tag PAGE. Alkaline phosphatase (+AP) treatment allows visualization of the non-phosphorylated bands. (D) Embryos injected with LPAR2MO or coinjected with LPAR2MO and 5 mismatch (5 mm) LPAR2 mRNA or 5 mmLPAR2SA mRNA. A mixture of FoxD3 and Dlx2 probes (which labels premigratory as well as migratory NC cells) was used to visualize the whole NC population. Asterisks indicate eyes. (E) Quantification of NC migration from embryos shown in D (18 embryos were analyzed). One-way ANOVA, P = 0.0025. Individual comparisons: \*, P \< 0.05. Error bars indicate SD.](JCB_201402093_Fig2){#fig2}

To better characterize which aspect of cell migration was affected in the absence of LPAR2, we performed in vitro cell migration assays and found that control and LPAR2MO cells had similar cell motility properties ([Fig. 3, A and B](#fig3){ref-type="fig"}). We then tested whether LPAR2MO cells might have an impaired response to signals known to guide NC migration in vivo. We performed chemotaxis assays where cells were exposed to an external source of stromal cell derived factor-1 (SDF1), a well-known NC chemoattractant ([@bib4], [@bib5]; [@bib44]; [@bib28]; [@bib59], [@bib60]; [Fig. 3, C and D](#fig3){ref-type="fig"}). Both control and LPAR2MO-injected cells were able to respond to SDF1 and migrate toward the source with similar efficiency ([Fig. 3 E](#fig3){ref-type="fig"} and [Video 1](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp2}). These results show that blocking LPA signaling does not block NC cell motility or their ability to respond to chemotactic cues. Our data also show that in 2D culture assays, LPAR2-depleted NC cells are able to migrate normally. This is in striking contrast to the situation in the 3D environment of the living embryo, in which NC migration requires LPAR2. One possible explanation for this discrepancy may lie in the physical nature of the embryo: in vivo, NC cells encounter physical barriers (i.e., the eye, otic vesicle, epibranchial placodes) and chemical inhibitors (i.e., class 3 semaphorins, Eph/ephrins) that restrict migration into specific territories. Such constraints do not exist in an open 2D culture.

![**Inhibition of LPAR2 does not affect cell motility or chemotaxis.** (A and B) Cell tracking analysis on cell clusters (A; *n* = 2,261 cells from four independent experiments; Student's two-tailed *t* test: P = 0.25) and single cells (B; *n* = 1,299 cells from three independent experiments; Student's two-tailed *t* test: P = 0.75). (C and D) Chemotaxis assay with controls (C) and LPAR2MO cells (D). Time projection of cell tracks color-coded according to their Chemotaxis index (from blue \[0.1\] to red \[0.9\]). (E) Chemotaxis index from experiments shown in C and D (mean chemotactic index of 22 explants from three independent experiments; Student's two-tailed *t* test: P = 0.1837).](JCB_201402093_Fig3){#fig3}

To test the idea that LPAR2 is required for cells to migrate into physical constraints, we developed a chemotaxis assay in which cells are forced to navigate through tunnels. The dimensions of these tunnels corresponded to the size of the NC streams observed in vivo ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp3}). NC cells were cultured on microfluidic chips containing tunnels of various widths corresponding to one nucleus diameter (10 µm), one cell diameter (25 µm), two cell diameters (50 µm), and six cell diameters (150 µm). All tunnels were one nuclei diameter in height (10 µm), thereby dictating that cells within a multilayered explant must rearrange themselves to squeeze into the tunnel (Fig. S2). We found that cells in control explants were capable of invading all channel widths ([Fig. 4, A, C, and E](#fig4){ref-type="fig"}), which indicates that substantial cell rearrangements had taken place. In contrast, LPAR2MO-injected cells consistently stalled at the entrance or in the first half of the tunnels ([Fig. 4, B, D, and E](#fig4){ref-type="fig"}; and [Video 2](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp4}), which suggests that LPAR2MO cells had a low plasticity and were deficient in their ability to exchange positions with their neighbors.

![**LPAR2 signaling is required for solid-like--to--fluid-like transition during NC EMT.** (A--D) Invasion assay with microfluidic tunnels. Bars, 50 µm. (E) Quantification of invasion assay (19 10-µm explants from seven independent experiments; Student's two-tailed *t* test: P = 0.279; 31 25-µm explants from nine independent experiments; Student's two-tailed *t* test: P = 0.006; 22 50-µm explants from seven independent experiments; Student's two-tailed *t* test: P = 0.0018; 29 150-µm explants from eight independent experiments; Student's two-tailed *t* test: P \< 0.001). (F--I) Spatial correlation kymographs. Projection of all time points (F) or temporal maps (H) where each line corresponds to a mean of three consecutive time points. Hot colors indicate a high level of correlation between two compared velocity vectors. (G) Comparison of correlation kymographs projections between control (left) and LPAR2MO (right). (I) Comparison of correlation kymographs over time between control (top) and LPAR2MO (bottom) cells. The broken line in the control data indicates at which distance between cells correlation is lost. That represents the threshold of solid-like--to--liquid-like behavior transition.](JCB_201402093_Fig4){#fig4}

To test the idea that a lack of LPAR2 impairs the ability of cells to exchange neighbors, we quantified the relative motion of cells within a group in control and LPAR2MO conditions. We cultured cells for 1--3 h on a 2D substrate and characterized the degree of alignment of velocity vectors by calculating the correlation function of the cell velocity field (see Materials and methods). Alignment of velocity vectors is expressed as a function of the relative position of the cells averaged over time ([Fig. 4, F and G](#fig4){ref-type="fig"}) or as a function of radial distance between cells and time ([Fig. 4, H and I](#fig4){ref-type="fig"}). Velocity vectors are perfectly aligned where this function is 1, and randomly aligned where the function is 0. In other words, cells move in the same direction where this function is 1, whereas their movements are not correlated where this function is 0. In vitro and in silico studies ([@bib26]; [@bib31]; [@bib15]) have shown that a population appears solid-like at scales smaller than the correlation length, but free to reshape at larger scales. Therefore, the characteristic length at which this function decays (the distance between two cells at which coordination is lost) qualitatively defines the response of the cell population to confinement. The ability to flow in order to take on the shape of a container is a characteristic of fluids, whereas solids have a structural rigidity making them resistant to such changes of shape. Hence, cell populations behave as solid-like when exposed to structures that are smaller than their correlation length whereas they behave as fluids in spaces that are bigger than their correlation length.

We found that, in control groups, movement of cells located anywhere within the group showed little correlation with neighbors, with a correlation length on the order of 25 µm, roughly corresponding to one and a half cell diameters ([Fig. 4 G](#fig4){ref-type="fig"}, left) in accordance with our observation that control NC cells were able to reorganize to pass through tunnels of 25 µm. In contrast, LPAR2MO cells displayed a solid-like behavior even over distances between 150 and 200 µm, roughly six to eight cell diameters ([Fig. 4 G](#fig4){ref-type="fig"}, right). This result means that LPAR2MO cells may need an infinite amount of time to reorganize in order to take on a shape smaller than 150 µm. This can explain why LPAR2MO cells were only able to partially enter tunnels of 150 µm but not smaller ones. These dynamics measurements were also seen to be constant over time ([Fig. 4, H and I](#fig4){ref-type="fig"}). This result indicated that LPAR2MO cells, despite being fully motile and responding accurately to chemotactic cues, tend to behave as a solid at the scale of hundreds of microns, making them unable to rearrange to invade narrow spaces. By comparison, control cells emerge as a fluid-like material at the scale of only a few tens of microns and as such are able to reorganize to pass through interstices. Thus, the acquisition of a fluid-like behavior allows CCM into interstices, whereas inhibition of this phase transition by blocking LPAR2 makes cell clusters too solid to pass.

Such an increase in the solid-like behavior observed in LPAR2MO cells could be caused by a decrease in cell motility or an increase in the cohesion of the tissue. Because cell motility of single or clustered cells was not affected by LPAR2 depletion ([Fig. 3, A and B](#fig3){ref-type="fig"}), we hypothesized that the observed phenotype might be caused by increased cell--cell adhesion slowing down cell rearrangements within the group. To determine whether cells lacking LPAR2 displayed stronger cell--cell adhesions, we performed a 2D culture dispersal experiment using control and LPAR2MO-injected cells ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp5}). Under these conditions, control NC cells are known to progressively spread in a radial fashion with cells at the border of the group, eventually breaking away as single cells within 5 h ([@bib14]). This dispersion is a direct consequence of the loss of cell--cell adhesion and can be quantified by measuring the area between the nearest neighbors using Delaunay triangulation ([@bib8]; [@bib3]). Control cells were able to efficiently disperse, whereas LPAR2MO cells remained as a group (Fig. S3 and [Video 3](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp6}). Altogether, our results show that LPAR2MO cells are as migratory and as responsive to external guidance cues as control cells but fail to dissociate and thus represent a partial EMT phenotype where motility is intact but cell--cell dissociation does not occur.

We next investigated the molecular effectors of LPA signaling that could explain the observed phenotype. We first looked for potential changes in cell--cell junction composition by performing immunostaining for N-cadherin in control and LPAR2MO cells ([Fig. 5 A](#fig5){ref-type="fig"}; quantification shown in [Fig. 5 B](#fig5){ref-type="fig"}). LPAR2-deficient cells showed stronger N-cadherin staining at the cell--cell junction ([Fig. 5 D](#fig5){ref-type="fig"}), as well as at the free membrane of the edge cells, than control cells ([Fig. 5 C](#fig5){ref-type="fig"}). A similar increase in other components of the cell--cell junction complex, such as p120-catenin ([Fig. 5 G](#fig5){ref-type="fig"}) and β-catenin, was also observed in vitro ([Fig. 5 H](#fig5){ref-type="fig"}) and in vivo ([Fig. 5 I](#fig5){ref-type="fig"}). However, there were no changes in the mRNA ([Fig. 5 E](#fig5){ref-type="fig"}) or total protein levels ([Fig. 5 F](#fig5){ref-type="fig"}) of these molecules, which suggests a more subtle regulation at the level of spatial distribution of the cell--cell adhesion complexes. To determine whether these effects were caused by altered traffic of adhesion components, we assessed N-cadherin endocytosis using pulse-chase analysis of N-cadherin fused to a HaloTag ([@bib63]) on the extracellular domain. Cells were coinjected with mRNAs encoding HaloTag--N-cadherin and membrane-mCherry, and incubated for a short time with the HaloTag ligand (green), which cannot penetrate the cell membrane. The excess ligand was then washed and cells were monitored. In control cells, most of the HaloTag--N-cadherin was seen in intracellular vesicles ([Fig. 5, J, M, and N](#fig5){ref-type="fig"}; and [Video 4](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp7}), whereas LPAR2MO cells had a strong accumulation of N-cadherin in the cell membrane and a reduced number of N-cadherin--positive vesicles within the cell ([Fig. 5, K, M, and N](#fig5){ref-type="fig"}; and Video 4). Importantly, expressing an activated form of Rab5, a well-known promoter of endocytosis, was sufficient to rescue the effect of LPAR2MO on N-cadherin internalization ([Fig. 5, L, M, and N](#fig5){ref-type="fig"}; and Video 4). These results indicate that LPA signaling is required for N-cadherin endocytosis during NC EMT.

![**LPAR2 signaling controls N-cadherin internalization.** (A) N-cadherin immunostaining in controls and LPAR2MO cells. Bar, 10 µm. (B) Mean normalized fluorescence intensity along the cell--cell contact area is plotted for controls (green curve) and LPAR2MO cells (magenta curve). Error bars indicate SEM. (C) Maximum fluorescence levels at the free edge (78 cells from 13 independent experiments; Student's two-tailed *t* test: P \< 0.001; error bars indicate SD). (D) Maximum fluorescence levels at the cell--cell junctions (48 contacts from 13 independent experiments; Student's two-tailed *t* test: P \< 0.001; error bars indicate SD) are shown for controls (green dots) and LPAR2MO (magenta dots). (E) RT-PCR for Sox 9 (NC marker), β-catenin, and N-cadherin from embryos at premigratory (stage 19) and migratory (stage 24) NC injected with control MO (CMO) or LPAR2MO. (F) Western blot for N-cadherin and tubulin from dissected NC and eye tissue of the embryos injected with CMO or LPAR2MO. (G) Localization of p120-GFP expressed in controls and LPAR2MO cells. (H and I) Immunostaining for endogenous β-catenin in controls and LPAR2MO cells performed in vitro (H) or whole mount staining of dissected cranial tissues (I). Boxed regions are enlarged on the right. (J--L) Pulse-chase assay with NC cells injected with N-cadherin HaloTag (green) and membrane-mCherry (magenta) in controls (J), LPAR2MO cells (K), or cells coinjected with LPAR2MO and activated Rab5 (L). Boxed regions are enlarged in the "zoom" column. (M) Normalized fluorescence intensity levels for N-cadherin at the cell membrane in controls (green), LPAR2MO cells (magenta), and LPAR2MO-CA-Rab5 cells (cyan). *n* = 73 cells from three independent experiments. One-way ANOVA: P \< 0.0001. Individual comparisons: \*\*, P \< 0.01; \*\*\*, P \< 0.001. Error bars indicate SD. (N) Normalized number of intracellular vesicles per cells in controls (green), LPAR2MO cells (magenta), and LPAR2MO-CA-Rab5 cells (cyan). *n* = 291 cells from three independent experiments. One-way ANOVA: P \< 0.0001. Individual comparisons: \*\*, P \< 0.01; \*\*\*, P \< 0.001. Error bars indicate SD. Bars: (G--I) 50 µm; (G and H, high magnification) 10 µm; (J--K) 20 µm.](JCB_201402093_Fig5){#fig5}

Higher levels of N-cadherin at the cell membrane do not systematically translate into stronger cell--cell adhesion. Cadherins need to be coupled to the actin cytoskeleton to mediate strong adhesive forces. Such coupling places components of the cell adhesion complex under tension. Therefore, to assess if the increased N-cadherin levels lead to increased tension at the cell membrane, we used a vinculin-tension sensor (VinTS) Förster resonance energy transfer (FRET) reporter containing two fluorophores separated by an elastic linker ([Fig. 6 E](#fig6){ref-type="fig"}). Vinculin is known to experience tension when involved in a cell--cell adhesion complex ([@bib38]; [@bib67]; [@bib52]; [@bib53]; [@bib25]). When this reporter is under tension the two fluorophores are pulled apart, abolishing FRET ([@bib20]). We first checked that endogenous vinculin localizes at the cell--cell junction in NC cells ([Fig. 6, A and B](#fig6){ref-type="fig"}) and is also found in focal adhesions ([Fig. 6 C](#fig6){ref-type="fig"}) as compared with another focal adhesion component ([Fig. 6 D](#fig6){ref-type="fig"}). Although the VinTS reporter has been extensively used by one of us before ([@bib20]), we performed several controls to validate the use of the VinTS in our system. First, we compared FRET of the VinTS measured at the cell--cell contacts to the FRET Module alone (Mod). The Mod construct only contains the two fluorophores in direct apposition without the elastic linker and acts as a control of maximum FRET efficiency. VinTS showed significantly reduced FRET ([Fig. 6 F](#fig6){ref-type="fig"}, green bar) compared with Mod ([Fig. 6 F](#fig6){ref-type="fig"}, blue bar). Second, we analyzed FRET after using several treatments that are known to directly affect tension between cells. Culturing cells under low calcium conditions to block cell--cell adhesion, blocking N-cadherin expression or decreasing actomyosin contractility using the Rho Kinase (ROCK) inhibitor Y27632, led to an increase in FRET activity ([Fig. 6 F](#fig6){ref-type="fig"}, brown bars) that indicates a release of tension. This result indicated that control NC cells have functional cell--cell adhesions and that the vinculin FRET reporter can be used to measure changes in tension across these junctions. We then used this FRET probe to compare control and LPAR2MO cells ([Fig. 6 G](#fig6){ref-type="fig"}). LPAR2MO cells showed a strong decrease in FRET indicating additional tension at the cell--cell contact after inhibition of LPA signaling ([Fig. 6 G](#fig6){ref-type="fig"}, pink bar). Importantly, no effect was observed when FRET measurements were performed at the cell--matrix interface to assess tension across focal adhesions ([Fig. 6 H](#fig6){ref-type="fig"}). This is consistent with our observation that silencing LPAR2 expression does not affect adhesion to the substrate or cell motility ([Fig. 3, A and B](#fig3){ref-type="fig"}). Altogether, these results show that blocking LPAR2 dramatically increases the amount of N-cadherin at the cell membrane and that this accumulation is translated into increased tension through vinculin. This suggests that, in LPAR2MO cells, the extra amount of membrane N-cadherin is coupled to the actin cytoskeleton and involved in functional junctions, thus explaining the lack of cell dissociation observed after LPA loss-of-function.

![**Lack of LPAR2 signaling generates increased tension at cell--cell junctions.** (A--C) Vinculin immunostaining in *Xenopus* NC cells. Vinculin localizes at cell--cell junctions (arrowheads in B) and at focal adhesions (arrowheads in C). (D) Immunostaining against Phospho-Paxillin. Nuclei are stained with DAPI (blue). Bars: (A) 50 µm; (B--D) 15 µm. (E) Diagram depicting how the VinTS FRET probe works. (F) Vinculin FRET at the cell--cell contacts with control FRET probe (Mod, blue) and VinTS in controls (green) or low cell--cell adhesion conditions (brown). *n* = 76 cells from three independent experiments. One-way ANOVA: P \< 0.001. Individual comparison: \*, P \< 0.05; \*\*, P \< 0.01. (G) Vinculin FRET at the cell--cell contacts in controls (green) and LPAR2MO cells (magenta). *n* = 64 cells from three independent experiments. Student's two-tailed *t* test: P \< 0.001. (H) Vinculin FRET in focal adhesions in controls (green) and LPAR2MO cells (magenta). *n* = 22 cells from three independent experiments. Student's two-tailed *t* test: P = 0.53.](JCB_201402093_Fig6){#fig6}

To further assess whether the altered N-cadherin traffic might explain the change of NC migratory abilities observed when LPA signaling is blocked, we tried to rescue LPAR2MO cells by manipulating N-cadherin binding, expression, or endocytosis. We first performed a cell dispersion assay ([Fig. 7, A--G](#fig7){ref-type="fig"}; and [Video 5](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp8}) in which NC cells injected with a control Morpholino normally break away as single cells ([Fig. 7 A](#fig7){ref-type="fig"}), whereas LPAR2MO cells fail to do so ([Fig. 7 B](#fig7){ref-type="fig"}). Dispersion defects could be rescued in LPAR2MO cells by lowering calcium ([Fig. 7 C](#fig7){ref-type="fig"}), blocking N-cadherin expression ([Fig. 7 D](#fig7){ref-type="fig"}), reducing N-cadherin binding in trans with a blocking antibody ([Fig. 7 E](#fig7){ref-type="fig"}), or increasing endocytosis with an activated Rab5 ([Fig. 7 F](#fig7){ref-type="fig"} and Video 5). Importantly, spatial correlation kymography analyses demonstrated that these treatments were also sufficient to dramatically lower the correlation length. This indicated that blocking N-cadherin in LPAR2MO cells was sufficient to restore a fluid-like behavior at scales similar to control cells ([Fig. 7, H and I](#fig7){ref-type="fig"}).

![**Inhibition of cell--cell adhesion rescues LPAR2 loss of function.** (A--F) Cell dispersion assay in controls (A), LPAR2MO cells (B), or LPAR2MO cells in low calcium/magnesium conditions (C), coinjected with N-Cadherin MO (D), incubated with N-Cadherin blocking antibody (E), or coinjected with activated Rab5 (F). (G) Dispersion analysis using Delaunay triangulation from experiments shown in A. *n* = 103 explants from 12 independent experiments. One-way ANOVA: P \< 0.0001. Individual comparison: \*\*\*, P \< 0.001; ns, not significant. (H) Spatial correlation analysis. The broken line represents the solid-to-fluid transition. (I) Quantification of the spatial correlation analysis; the plot shows distances at which the alignment of velocity vectors falls below 0.5 for each experimental condition. *n* = 17 explants from three independent experiments. One-way ANOVA: P \< 0.0001. Individual comparisons: \*\*\*, P \< 0.01.](JCB_201402093_Fig7){#fig7}

Further, we performed an invasion assay using microfluidic tunnels and found that LPAR2MO cells that were preincubated with the blocking antibody against N-cadherin (NCD2) were able to invade narrow spaces ([Fig. 8, B, D, and E](#fig8){ref-type="fig"}) in a manner similar to that seen in control cells ([Fig. 8, A, B, and E](#fig8){ref-type="fig"}; and [Video 6](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp9}). Finally, we tested the ability of a mild inhibition of N-cadherin or increased endocytosis to rescue migration of LPAR2MO cells in vivo. We first grafted LPAR2MO NC cells directly into control hosts or first incubated them with the blocking antibody against N-cadherin (NCD2) before transplantation ([Fig. 8 F](#fig8){ref-type="fig"}). LPAR2MO cells were unable to migrate after being grafted into hosts ([Fig. 8, H and K](#fig8){ref-type="fig"}), whereas LPAR2MO cells treated with NCD2 ([Fig. 8, I and K](#fig8){ref-type="fig"}) migrated as efficiently as control cells ([Fig. 8, G and K](#fig8){ref-type="fig"}). Similarly, coinjection of LPAR2MO with an mRNA encoding constitutively active Rab5 was sufficient to restore in vivo NC migration ([Fig. 8, J and K](#fig8){ref-type="fig"}). These results show that inhibition of N-cadherin or activation of N-cadherin endocytosis in LPAR2-deficient cells is sufficient to restore the plasticity required for NC migration under physical constraints in vitro and in vivo.

![**Inhibition of N-cadherin restores migration of LPAR2 morphant cells through interstices in vitro and in vivo.** (A--D) Invasion assay with LPAR2MO cells (A and C) or LPAR2MO cells incubated with N-cadherin blocking antibody (NCD2; B and D). (E) Quantification of the invasion assay shown in A--D. 50 µm, *n* = 27 explants from four independent experiments. One-way ANOVA: P \< 0.0001. 150 µm, *n* = 36 explants from four independent experiments. One-way ANOVA: P \< 0.0001. Individual comparisons: \*\*\*, P \< 0.001. Error bars indicate SD. (F) Grafting procedure. (G--J) Grafts of NC injected with FDx (G), FDx and LPAR2MO directly into control hosts (H), FDx and LPAR2MO treated with N-cadherin antibody (NCD2) before transplantation (I), or LPAR2MO cells overexpressing CA-RAb5 (J). Asterisks indicate eyes. (K) Analysis of NC migration of the experiment shown in G--J. 35 embryos were analyzed. One-way ANOVA: P \< 0.0001. Individual comparisons: \*\*, P \< 0.01; ns, not significant. Bars: (A--D) 50 µm; (G--J) 0.5 mm.](JCB_201402093_Fig8){#fig8}

We have previously shown that cell--cell interactions are required for in vivo CCM of NC cells ([@bib7]; [@bib59]; [@bib8]). Cell contacts polarize cells, rendering them able to sense chemotactic cues in a process coined collective chemotaxis ([@bib59]). Therefore, lowering cell--cell adhesion even further than in control cells should favor cell dispersion over CCM by abolishing cell cooperation and thus inhibit NC migration in vivo but not in vitro. To test this idea, we analyzed the effect of reducing cell--cell adhesion in a 2D in vitro dispersion assay ([Fig. 9 A](#fig9){ref-type="fig"}) and found that NC cells cultured under low calcium/magnesium conditions (orange curve) or injected with a dominant-negative form of N-cadherin (blue curve) dissociate faster than control cells (green curve). Then we performed a similar experiment in vivo by reducing cell--cell adhesion by specifically blocking N-cadherin expression or using deletion constructs that are known to act as dominant-negatives ([Fig. 9, B--E](#fig9){ref-type="fig"}). Indeed, blocking N-cadherin expression ([Fig. 9 B](#fig9){ref-type="fig"}) or overexpressing its truncated forms lacking the cytoplasmic or β-catenin binding domains ([Fig. 9, C and D](#fig9){ref-type="fig"}) impaired in vivo NC migration ([Fig. 9 E](#fig9){ref-type="fig"}). These observations, together with previously published results ([@bib59]), show that cells with low cell--cell adhesion dissociate faster but are unable to cooperate properly in order to undergo the directional collective migration characteristic of the cephalic NC population.

![**In vivo CCM requires a basal level of cell--cell adhesion.** (A) Dispersion assay of controls (green curve) or control cells cultured in low calcium/magnesium conditions (orange curve), or cells expressing N-cadherin dominant-negative (N-cadh ΔCyto, blue curve) analyzed by triangulation. Control versus low Ca^2+^/Mg^2+^, *n* = 11 explants from four independent experiments. Student's two-tailed *t* test: \*\*\*, P = 0.0093. Control versus N-CadhΔCyto, *n* = 15 explants from four independent experiments. \*\*\*, P = 0.0094. Error bars indicate SD. (B--D) Analysis of NC migration after inhibition of N-cadherin using a Morpholino (B), overexpression of deletion constructs lacking the cytoplasmic domain (C), and a β-catenin binding domain (D). Asterisks indicate eyes. (E) Distance of NC migration from experiments shown in B--D. 77 embryos were analyzed. One-way ANOVA: P \< 0.0001. Individual comparisons: \*\*, P \< 0.01; \*\*\*, P \< 0.001. Error bars indicate SD. (F--I) Model of NC migration. (F) NC cells progressively dissociate while migrating toward the ventral side of the head. The color code indicates the range of partial mesenchymal phenotypes with a transition from an early EMT/solid-like (red) to a late-EMT/fluid-like (green) phenotype. (G) At the onset of EMT, cells are motile but too tightly attached to one another to invade other tissues, as they express high levels of N-cadherin in the membrane. (H) After cell--cell dissociation triggered by LPA/LPAR2--dependent N-cadherin internalization, NC cells can migrate and invade other tissues. (I) Dramatic reduction of cell--cell adhesion promotes a fully mesenchymal phenotype that favors dispersion of individual cells in vitro but impairs directional migration in vivo.](JCB_201402093_Fig9){#fig9}

Discussion
==========

Overall our results indicate that LPA signaling is activated at the onset of NC migration, and this in turn controls the internalization of N-cadherin. This effect depends on LPAR2 phosphorylation at Ser^324^. The internalization of N-cadherin reduces cell--cell adhesion during EMT and converts an initially rigid NC population into a more fluid structure able to adapt to physical constraints ([Fig. 9 F](#fig9){ref-type="fig"}). In early EMT NC cells, LPA/LPAR2 signaling is low and cells are motile but tightly coupled by N-cadherin ([Fig. 9 G](#fig9){ref-type="fig"}). It is important to note that despite maintaining strong cell--cell adhesion early migratory NC cells have already acquired typical mesenchymal properties such as high motility and the ability to respond to chemotactic cues. Thus, they can no longer be classified as epithelial cells. In late-EMT NC cells, LPA signaling triggers N-cadherin internalization. Low N-cadherin levels allow cells to both rearrange and cooperate via transient contacts ([Fig. 9 H](#fig9){ref-type="fig"}). If cell--cell junctions are further disrupted, cell dispersion is enhanced while cell cooperation is abolished, which leads to a loss of directional migration ([Fig. 9 I](#fig9){ref-type="fig"}). Cells that are strongly adherent with one another can undergo directional migration but will fail to invade narrow spaces. They behave as a partially mesenchymal cell population with solid-like properties and as such get stuck due to excessive structural rigidity reminiscent of a solid unable to pass through a hole smaller than its own size. Conversely, cells with loose cell--cell adhesion behave in a fluid-like manner and are thus more pliable, endowing them with the ability to pass through interstices. However, this state cannot be considered fully mesenchymal either because cell polarity and directionality require repeated transient but functional cell--cell adhesions. Forcing NC cells to acquire an archetypical mesenchymal phenotype by abolishing cell--cell junctions to generate purely single cells actually impaired migration. Altogether, these observations indicate that there are various degrees of partial mesenchymal phenotypes. These various states can be distinguished on the basis of tissue fluidity and the ability to rearrange within a given time scale, and the fact that this property is largely independent from their motile capabilities. The conventional definition of epithelial and mesenchymal cells implies that they either behave as part of a tissue or as individual cells, respectively. We propose here that this definition is not sufficient to fully characterize the cell behavior observed during collective migration of mesenchymal cells, as they are typically migratory mesenchymal cells that interact with neighbor cells within a tissue. Consequently the canonical definition of EMT does not fully describe the changes occurring during CCM, and we would like to suggest that a solid-like--to--fluid-like transition should be incorporated to define EMT during collective behaviors. This solid-like--to--fluid-like transition is reminiscent of the one used to describe surface tension by M.S. Steinberg (e.g., [@bib17]).

Thus, such a change of plasticity appears to be an essential part of the EMT program, which allows invasion into regions imposing physical constraints without impairing the cell--cell interactions needed for CCM. Similar fine-tuning of the cell--cell adhesion properties might happen in other systems where EMT and CCM coexist, such as cancer metastasis or gastrulation. In addition, the need to maintain efficient cell interactions to allow for collective migration might in part explain the counterintuitive observation that many tumors have de novo expression of cell--cell adhesion molecules while undergoing EMT ([@bib64]; [@bib61]). Down-regulation of cadherins favors emigration of the primary tumor cells from their host organ ([@bib42]; [@bib45]) but might also impair cooperation among cancer cells. Alternatively, altering cell--cell adhesion, without cancelling it, would allow cancer cells to both successfully detach from a tissue and preserve cooperative behaviors required for long-distance migration (i.e., contact-dependent polarity and survival).

The role of mechanical forces is highly debated in cancer metastasis ([@bib65]). This led some to theoretically explore analogies between tumor metastasis and phase transition from solid to liquid to gas ([@bib13]). The results described here provide experimental support and a molecular mechanism for such ideas, and indicate that in vivo CCM is the result of a balance between physical interactions among migratory cells and the mechanical properties of the local environments. Overall, our findings contribute to a better understanding of the relative importance of cell--cell versus cell--environment interactions during collective movements.

Previous studies have shown that inhibition of Rho/ROCK signaling in zebrafish impairs NC migration ([@bib9]). An opposite role for Rho/ROCK signaling controlled by LPA has been proposed in chick NC. [@bib21] showed that adding LPA to trunk NC cultures activated RhoA/B and blocked cell emigration. It is not known which LPA receptors are present in trunk NC cells in chicks, and the phenotype induced by adding LPA in the culture medium is likely to be the result of the activation of multiple signaling cascades. Here we specifically blocked LPAR2 and showed an impairment in cell--cell dissociation. We do not know the effect that activation or inhibition of other LPA receptors could have on NC migration in our system.

Genetic studies with LPA receptor--null mice have suggested some degree of redundancy, as LPAR2-null mice have no obvious phenotype, but the LPAR1/LPAR2 double-null mice have a higher lethality than LPAR1-null mice ([@bib10], [@bib12]). It is common to find this degree of redundancy between signaling pathways in mice and not in other animal models like *Xenopus*, which allowed using this animal model to discover this novel function for LPAR2. Previous studies in *Xenopus* embryos have shown that LPAR2 is involved in wound healing by controlling the actin cytoskeleton ([@bib56]). Whether the actin cytoskeleton is modulated by LPAR2 signaling in our cells remains to be investigated. Interestingly, our findings on the role of ATX and subsequent LPA signaling via LPAR2 are consistent with the biological activity reported in cancer models ([@bib23]), and suggest that *Xenopus* NC cells could be an adequate model to study cell behaviors important for cancer metastasis.

Materials and methods
=====================

PCR primers
-----------

### For LPAR2 mutations.

Forward primer: 5′-TGAATTCATGAA*c*CA*a*TG*t*TT*c*TA*c*AATGAGAGTATTAAGTTC-3′. Mutations are represented by lower-case italicized letters. For the Ser^324^ point mutation of LPAR2, pCS2+/5 mm LPAR2 whole plasmid was amplified using the following primers. S324\>A forward (Fw), 5′-ACTAATACAGAGAGGAGAGTCTTGGCTGAC-3′; S324\>A reverse (Rv), 5′-TGCCTTAAGGGAAGCCGGTGAGTATTTGG-3′. For making 5′ UTR-LPAR2-GFP shown in [Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201402093/DC1){#supp10}, 5′ UTR-LPAR2 ORF cDNA was amplified by 5′ UTR-LPAR2 forward, 5′-TCGAATTCGACAGGCGGAGGC-TGAGCTGTA-3′; and AgeI-LPAR2 reverse primer, 5′-CGACCGGTGCAAGACTGCATTCTCTCATTG-3′.

### For HaloTag--N-cadherin.

N-cad Fw, 5′-CAGCATCGATGTGCCGGAAAGAGCCCTTCC-3′; Rv, 5′-AGTCTAGATTCAGTCGTCGCTCCCTCCGTAC-3′. First, the restriction sites for HaloTag fusion protein were introduced into XN-cadherin by PCR with the following sets of primers. N-cadSPFw, 5′-CGTTTATGCAAGACAGGATTTCTTGAGGATG-3′; N-cadSPRv, 5′-AGTTCCCCCGAGTGCTTCAACTGGTCCCT-3′; HaloTagFw, 5′-AGTATGGCAGAAATCGGTACTGGCTT-3′; HaloTagRv, 5′-CGTGGTTGGCTCGCCGGAAATCTC-3′. Then the pro-domain of N-cadherin was removed by another PCR, N-cadEC1Fw: 5′-AATCACGCGTGATTGGGTTATTCCACCAAT-3′.

### For semiquantitative RT-PCR.

XN-cadh-U, 5′-CCCTTTATCTTTGAACTTCCTTA-3′; XN-cadh-D, 5′-TTATCTCTGACATCATCTTCTGG-3′; Xβ-Cat-U, 5′-CTATCCAGTTGATGGACTTCCTG-3′; Xβ-Cat-D, 5′-TCTGACCAAATAAAGGACCAGAA-3′.

RNAs were extracted from whole embryos (2--3 embryos) or 20 pieces of dissected cranial NC cells using RNeasy Protect Mini kit (QIAGEN). The cDNA was reverse-transcribed by SuperScript II Reverse transcription (Life Technologies). For semiquantitative PCR, PCR cycles were decided by pilot experiment using the whole embryos' cDNA. The program for amplification was 96°C for 1 min, 96°C for 15 s, 55°C for 30 s, and 72°C for 45 s × cycles as follows: Sox9 (29 cycles), Xβ-Cat (27 cycles), N-cadh (27 cycles), ornithine decarboxylase 1 (ODC; 23 cycles). Primers for RT-PCR for Ep-Ker, ODC, and muscle actin were described in Xenbase ([@bib6]), and Sox9 ([@bib39]), Snail2 ([@bib2]), and FoxD3 ([@bib49]) have been described previously.

Reagents and solutions
----------------------

The following reagents and solutions were used. Agarose (BP1356-100; Thermo Fischer Scientific), BSA (A4503; Sigma-Aldrich), fibronectin (F1141; Sigma-Aldrich), FDx (D1821; Sigma-Aldrich), gelatin (G1890; Sigma-Aldrich), methylcellulose (M0387-100; Sigma-Aldrich), Mowiol 40-88 (81386; Fluka), penicillin-streptomycin (P4458; Sigma-Aldrich), Rhodamine-dextran (D1824; Sigma-Aldrich), sucrose and (27480.294; VWR). Danilchick's medium 1×: 53 mM NaCl, 5 mM NA~2~CO~3~, 4.5 mM potassium gluconate, 32 mM sodium gluconate, 1 mM MgSO~4~-7H~2~0, 1 mM CaCl~2~, and 0.1% BSA. MEMFA: 1 mM MOPS, 2 mM EGTA, 1 mM MgSO~4~, and 3.7% formaldehyde. Normal amphibian medium (NAM): 110 mM NaCl, 2 mM KCl, 1 mM Ca(CO~3~)~2~, 1 mM MgSO~4~, 0.1 mM EDTA, 1 mM NaHCO~3~, and 2 mM sodium phosphate. NTMT: 0.1 M NaCl, 0.1 M TrisHCl, pH 9.5, 50 mM MgCl~2~, and Tween 0.1%. PBS 1×: 137 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~, 1.8 mM KH~2~PO~4~, 1 mM CaCl~2~-2H~2~O, and 0.5 mM MgCl~2~-6H~2~O.

Microfabrication of microfluidic tunnels
----------------------------------------

Two-layer chips were designed using the AutoCAD 2009 software (Autodesk). High-resolution soda-lime masks for the microchannel layer, and emulsion masks for the chamber layers were obtained from JD Photo-Tools. 3-inch silicon wafers were ordered from Virginia Semiconductor Inc. Molds were processed in two steps in the cleanroom facility of the London Centre for Nanotechnology. AZ5214E resist (MicroChemicals GmbH) was spun at 5,000 rpm and processed as a negative resist using standard procedures to create the mask for the microchannel layer. The patterned wafer was then etched for 10 or 20 µm using a deep reactive ion etcher (Surface Technology Systems ICP DRIE; SPTS Technologies), plasma cleaned in a TePla plasma cleaner (PVA TePla) and further cleaned with fluoric acid. A second 150-µm-thick SU-8-2100 photoresist (MicroChem Corp.) layer was then deposited and processed using standard microfabrication techniques ([@bib19]) to generate the mold for the explant culture chamber and the chemoattractant channel. The mold was finally cleaned once more in the TePla plasma cleaner. It was then plasma activated (using a Plasma Clean 4; Ilmvac), plunged in 1% tridecafluoro-1,1,2,2-tetrahydrooctyl-1-dimethylchlorosilane (13F; MCC) in toluene for 30 min, washed, dried, and baked at 55°C for 15 min. Polydimethyl methylhydrogen siloxane (PDMS) casts were prepared by mixing 1:10 parts of curing agent to base Sylgard 184 elastomer (Dow Corning Corp.). The PDMS mix was degassed and poured onto the 13F-coated patterned wafer and cured at 55°C overnight. Then, input/output were created using a biopsy punch and the culture chamber was opened by cutting out a square of PDMS with a surgical scalpel. PDMS casts were further exposed to plasma for 30 s and irreversibly bonded to 35-mm-diameter glass-bottom dishes (WillCo; Intracell). Finally, the assembled chips were baked for 15 min at 75°C.

Spatial correlation analysis
----------------------------

This method allows us to assess the degree of alignment between cells within a group and to express this alignment as a function of distance. Nuclei are tracked over time and their displacement between two consecutive time points give a series of velocity vectors that can then be systematically compared with one another. For statistical comparisons, one has to choose a threshold of alignment. Then, the mean distance between cells at which this mean alignment is reached is used to compare experimental conditions. We chose the distance at which the mean alignment of velocity vectors across the population is 0.5 to compare experimental conditions. Further detail of the strategy to obtain velocity vectors is provided hereafter.

To quantify the spatial correlations of cell displacements, the velocity fields are first calculated using an optical flow method on images of stained nuclei (cells were injected with mRNA for nuclear-mCherry). Displacements are quantified from pairs of images 5 min apart, at a resolution of 2.05 µm/pixel. The spatial correlation function of the velocity field is then calculated at each time step using the methodology developed by [@bib26]. The 2D correlation function g(δr) is introduced to characterize the mean degree of coordination between a cell moving at the origin moving along the x axis, and another cell located at a position δr with respect to the first. This enables one to distinguish correlations along the direction of motion and correlations in the transverse direction. Quantitatively, the correlation function at any instant is calculated from:$$g\left( {\delta r} \right) = \frac{\left\langle {v\left( r \right) \cdot v\left( {r + R\left( r \right)\delta r} \right)} \right\rangle r}{\left\langle v^{2} \right\rangle r},$$where R(r) is the transformation rotating the velocity vector v(r) along the horizontal x axis. The normalization of the function ensures that g = 1 where cells' velocities are fully aligned, and 0 where orientations are random.

Spatial maps were obtained by averaging over all time steps between 0 and 75 min. Time-resolved maps were obtained by calculating, at each time point, the radial mean of g(δr) over 200 min (3 h, 20 min). The distance at which such function decays can be interpreted as the correlation length of the cell population.

Statistical analysis
--------------------

Comparison of percentages was performed using contingency tables as described previously ([@bib54]). Two datasets were considered significantly different (null hypothesis rejected) if T \> 3.841 (\*, α = 0.05), T \> 6.635 (\*\*, α = 0.01), or T \> 10.83 (\*\*\*, α = 0.001). Normality of datasets was tested using the Kolmogorov-Smirnov's test, d'Agostino and Pearson's test, and Shapiro-Wilk's test using Prism 4 (GraphPad Software). A dataset was considered normal if found as normal by all three tests. Datasets following a normal distribution were compared with a Student's *t* test (two-tailed, unequal variances) in Excel (Microsoft) or a one-way analysis of variance (ANOVA) with a Dunnett's multiple comparisons post-test in Prism 4. Datasets that did not follow a normal distribution were compared using a Mann Whitney's test or a nonparametric ANOVA (Kruskal-Wallis with Dunn's multiple comparisons post-test) using Prism 4. Cross-comparisons were performed only if the overall P-value of the ANOVA was \<0.05. Scatter plots show individual values for each individual experiment in each condition, and error bars show the mean and the standard deviation. Box and whiskers plot: the box extends from the 25th to the 75th percentile; the whiskers show the extent of the whole dataset. The median is plotted as a line inside the box.

Delaunay triangulation
----------------------

In brief, individual nuclei were first automatically detected using the Particle Analysis tool in ImageJ. Then, xy positions of all nuclei were used to build triangles between the nearest neighbors with the Delaunay Triangulation plug-in. Areas of individual triangles are extracted. An average triangle area is calculated for each explant and the values were then normalized according to the mean of the control batch of each experiment. It is important to note that triangle area distribution is exponential. Thus, to perform statistical analysis, the datasets are converted into logarithms of areas that follow a normal distribution. Paired and multiple statistical comparisons were made as described in the Statistical analysis section.

Cell tracking
-------------

Cell tracking was performed with the Manual Tracking plug-in in ImageJ or with spot tracking function in Imaris (Bitplane). In all cases nuclear staining was used to follow individual cells over time. Directionality, velocity, and chemotaxis index (also known as the forward motion index) were extracted using the Chemotaxis Tool plugin in ImageJ or calculated from data generated by the Imaris tracking tool.

NC grafts
---------

The appropriate morpholino oligo and FDx or rhodamine-dextran (RDx; 1 µg/µl, mol wt 1,000; Molecular Probes) were injected into two-cell-stage embryos. Embryos at stage 18 were immobilized in a Petri dish filled with plasticine. The pigmented ectoderm layer located above the NC region was carefully removed using an eyebrow knife. NC cells can be mechanically detached from their surrounding tissues by applying gentle pressure on the side of the neural fold, passing the eyebrow knife from lateral to medial a few times. To perform the graft, a given NC explant has to first be taken from a donor embryo, then a similar procedure is immediately done on the host embryo. The NC explant coming from the donor is then placed into the wound of the host and kept in place by placing a square glass coverslip on top for 15 min. The coverslip is then removed and embryos are left to heal. Further details on grafting procedures can be found elsewhere ([@bib14]; [@bib60]).

Gene knockdown
--------------

Gene knockdown of Autotaxin, LPAR1, LPAR2, and N-cadherin ([@bib41]) was done by injection of morpholino oligonucleotides (MOs; Gene Tools, LLC). Morpholinos sequences were as follows XlAutotaxin, 5′-CTGAATCCGTTTTTCATTGCCATAG-3′; XlLPAR1, 5′-ACTCTGAAAGAGAAGCCATTTTAGC-3′; and XlLPAR2, 5′-ATAAAAGCACTGATTCATCTTGAGT-3′. ATX morpholino was provided by L. Dale (University College London, London, England, UK).

In situ hybridization
---------------------

Embryos were fixed overnight at 4°C in MEMFA before being dehydrated by several baths in pure methanol. Embryos were then rehydrated by solutions of decreasing methanol concentration, washed in PBS, and bleached in a peroxide solution to remove skin pigments. After bleaching a short postfixation in formaldehyde 3.7% was performed. Embryos were then incubated overnight at 65°C in formamide-based hybridization buffer containing a digoxigenin-labeled antisense probe against the gene of interest. Probes are washed in Formamide-based washing solutions, then washed in PBS 0.1% Tween, incubated in a serum-based blocking solution, and left overnight at 4°C in blocking solution containing the anti-digoxigenin antibody coupled with alkaline phosphatase. Staining was achieved by incubating embryos in a pH 9.5 solution containing NBT and BCIP in equal proportions.

Immunostaining
--------------

Cells were cultured on fibronectin-coated dishes, left to migrate for a few hours, fixed in 4% PFA for 30 min, blocked in a serum-based solution, incubated for 2 h with a primary antibody, quickly washed in PBS, and incubated 1 h with a secondary antibody mixed with DAPI or phalloidin if necessary. Primary antibodies: rat anti--N-cadherin (MNCD2; Developmental Studies Hybridoma Bank), rabbit anti--β-catenin (ab6302; Abcam), and mouse anti-vinculin (V9131; Sigma-Aldrich). Secondary antibodies were all Alexa Fluor--coupled immunoglobulins from Invitrogen (Alexa Fluor 488 or 555).

NC cell culture
---------------

*Xenopus* cranial NC cells were dissected as described in [@bib14]. In brief, at around stage 18 the pigmented epidermal layer is removed, then NC cells are gently taken out by microdissection. When needed, cell dissociation was performed by putting the NC explants in Ca^2+^/Mg^2+^-free medium for a few minutes before transferring them to normal culture medium. All cell cultures were performed on Fibronectin-coated Petri dishes.

cDNAs and expression constructs
-------------------------------

cDNA clones were obtained from the I.M.A.G.E. consortium. *Xenopus* autotaxin, I.M.A.G.E. 5570505; Xl-LPAR2 (EDG4), I.M.A.G.E. 6864256. *Xenopus* LPAR1 cDNA was a gift from J. Chun (The Scripps Research Institute, San Diego, CA). Specificity of LPAR2 MO was tested with a mutant LPAR2 including five mismatches in MO target sequences, and different LPAR2 mutants were also created by PCR (sequence given in the Gene knockdown section). For HaloTag--N-cadherin, *Xenopus* N-cadherin ORF was amplified by primers shown in the PCR primers section, and subcloned into pCSf107mT vector. HaloTag cDNA was inserted between N-cadherin prodomain and EC1.

Pulse-chase assay (HaloTag in situ labeling)
--------------------------------------------

At the eight-cell stage, HaloTag N-cadherin mRNA (500 pg/embryo) and membrane-mCherry mRNA (300 pg/embryo) were injected, and the embryos were cultured until stage 19. HaloTag-N-cadherin--expressing NC explants were dissected and preincubated for 30 min at room temperature with Alexa Fluor 488--nonpermeable HaloTag ligand solution in 1× Marc's modified Ringer (MMR; 1:1,000, Promega; [@bib35]), and the excess ligands were washed. Then labeled NC cells were cultured on fibronectin-coated coverslips (Tissue Tek II; Nalgene), and time-lapse imagining was performed (LSM 510 Meta; Carl Zeiss) immediately after cell attachment. The lens used for this imaging was a Plan-Apochromat 63×/1.4 oil objective. The temperature was ∼23°C. The imaging medium was Immersol 518F (Carl Zeiss). Images were obtained and analyzed with LSM 510 version 3.2 microscope operation software and Zeiss Image Browser (both from Carl Zeiss).

Phostag PAGE and Western blotting
---------------------------------

Phos-tag PAGE and Western blotting were performed as described previously ([@bib29]; [@bib30]; [@bib55]). The protein samples for phosphorylation analyses were prepared from *Xenopus* tissues lysed in PLC buffer with 0.5 mM sodium orthovanadate as a phosphorylation inhibitor. Phos-tag gel contains 50 µM phos-tag chemical compound in 12.5% acrylamide gel (SuperSep Phos-tag; Wako Chemicals USA). After electrophoresis, Phos-tag PAGE gels were rinsed in Tris-glycine blotting buffer containing 10 mM EDTA for 10 min three times, and twice without EDTA. For the control of protein dephosphorylation of LPAR2 cytoplasmic domain, we performed alkaline phosphatase treatment of protein lysates for 2 h at 50 C°. Antibodies for WB were as follows: monoclonal anti-Myc antibody (1:2,000 dilution, 9E10; Santa Cruz Biotechnology, Inc.), polyclonal rabbit anti-LPAR2 antibody (1: 375, HPA019616; ATLAS Antibodies), monoclonal anti--N-cadherin antiserum (1:200, MNCD2; Developmental Studies Hybridoma Bank), and monoclonal anti--α-tubulin antibody (1:5,000, B-5-1-2; Sigma-Aldrich).

VinTS FRET
----------

Samples for analysis of FRET by acceptor photobleaching were imaged using a laser scanning confocal microscope (LSM 510 Meta) and a 25× NA 1.4 Ph2 or 63× Plan Apochromat NA 1.4 Ph3 oil objective lens as specified. The CFP and YFP channels were excited using the 440-nm diode laser and the 514-nm argon lines, respectively. The two emission channels were split using a 545-nm dichroic mirror, which was followed by a 475--525-nm bandpass filter for CFP and a 530-nm longpass filter for YFP (Chroma Technology Corp). Pinholes were opened to give a depth of focus of 2 mm for each channel. Scanning was performed on a sequential line-by-line basis for each channel. The gain for each channel was set to ∼75% of dynamic range (12-bit, 4,096 gray levels) and offset such that backgrounds were zero. Time-lapse mode was used to collect one prebleach image for each channel followed by bleaching with a minimum of 50 iterations of the 514-nm argon laser line at maximum power (to bleach YFP). A second postbleach image was then collected for each channel. Control nonbleached areas were acquired for all samples in the same field of view as bleached cells to confirm specificity of FRET detection. Pre- and post-bleach CFP and YFP images were then imported into ImageJ for processing (AccpbFRET plugin; [@bib48]). Within this, all pixels were reregistered (using the Fast Hartley Transform algorithm) to correct for any shifts in the xy plane; bleed-through between donor and acceptor channels and efficiency of acceptor photobleaching were all accounted for in the analysis.

Invasion assay in microfluidic tunnels
--------------------------------------

The closed compartment of the microchip was loaded with a solution of SDF-l (0.25 µg/ml), and NC explants were labeled with nuclear-mCherry and membrane-GFP, or nuclear and membrane-mCherry were seeded in front of each tunnel. The chip was sealed and imaged on an upright microscope (i80; Nikon) with a 20× lens.

Online supplemental material
----------------------------

Fig. S1 shows that LPAR2 and Autotaxin are required for NC migration. Fig. S2 details the use of a microfluidic chamber to test 2D migration under physical constraints. Fig. S3 provides the results of Delaunay triangulation analyses of a cell dispersion assay. Video 1 shows how control and LPAR2MO-injected NC cells respond to Sdf-1 chemoattraction. Video 2 shows how NC cells migrate through various sizes of microfluidic tunnels. Video 3 shows a dispersion assay with controls and LPAR2MO cells. Video 4 monitors N-cadherin internalization using HaloTag pulse labeling. Video 5 shows that the impaired LPAR2MO cell dispersion is rescued by modification of cell--cell adhesions. Video 6 shows that functional blocking antibody of N-cadherin rescues LPAR2MO phenotype in microfluidic tunnel. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201402093/DC1>.
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